Human antibody variable region gene usage in HIV-1 infection

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 11, Issue 1, 1996, Pages 31-38

  Wisnewski, Adam ^a   Cavacini, Lisa ^a   Posner, Marshall ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Antibody gene usage; Heavy chain variable region; Human immunodeficiency virus type 1; Human monoclonal antibodies

Indexed keywords

ANTIBODY PRODUCTION; ANTIBODY STRUCTURE; GENE EXPRESSION; GENE STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN VARIABLE REGION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030026943     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199601010-00004     Document Type: Review

References (57)

1. Pantaleo G, Graziosi C, Fauci AS. New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993;328:327-33.
2. Amadori A, Zamarchi R, Ciminale V, et al. HIV-1-specific B-cell activation: a major constituent of spontaneous B cell activation during HIV-1 infection. J Immunol 1989;143: 2146-52.
3. Knowles D, Chamulak G, Subar M, et al. Lymphoid neoplasia associated with the acquired immune deficiency syndrome. Ann Intern Med 1988;108:744-9.
4. Amadori A, Chieco-Bianchi L, B-cell activation and HIV-1 infection: deeds and misdeeds. Immunol Today 1990;11: 374-9.
5. Muller S, Wang H, Silverman G, Bramlet G, Haigwood N, Kohler H. B-cell abnormalities in AIDS: stable and clonally restricted antibody response in HIV-1 infection. Scand J Immunol 1993;38:327-34.
6. H clonal defect in HIV-1-positive individuals reflects a B-cell maturational arrest. Blood 1991;78:175-9.
7. Andris JS, Johnson S, Zolla-Pazner S, Capra JD. Molecular characterization of five anti-human immunodeficiency virus type 1 antibody heavy chains reveals extensive somatic mutation typical of an antigen-driven immune response. Proc Natl Acad Sci USA 1991;88:7783-8.
8. Kohler H, Muller S, Nara P. Deceptive imprinting in the immune response against HIV-1. Immunol Today 1994;15: 475-8.
9. K occurs in polyclonal activated B cells. Proc Natl Acad Sci USA 1990;87:4932-6.
10. Stewart A, Schwartz R. Immunoglobulin V regions and the B cell. Blood 1994;83:1717-30.
11. Adderson EE, Shackelford PG, Quinn A, Carroll WL. Restricted Ig heavy chain V gene usage in the human antibody response to Hemophilus influenza capsular polysaccharide. J Immunol 1991;147:1667-74.
12. H 4-21 gene segment. J Immunol 1993;151:1051-9.
13. Newkirk MM, Capra JD. Restricted usage of immunoglobulin variable-region genes in human autoantibodies, 203-220. In: Honjo T, Alt FW, Rabbitts TH, eds., The immunoglobulin genes. San Diego: Academic Press, 1990.
14. Kipps TJ, Tomhaven E, Pratt LF, Duffy S, Chen PP, Carson DA. Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1989;86:5913-21.
15. H gene expression in chronic lymphocytic leukemia. Int Immunol 1989;1:360-4.
16. Schroeder HW, Hillson JL, Perlmutter RM. Early restriction of the human antibody repertoire. Science 1987;2328: 791-5.
17. + B lymphocytes. In: Weiss L, eds. Bone and the immune system. Washington, D.C.: The Society for Experimental Biology and Medicine, 1991:226-41.
18. Grimaldi L, Roos R, Devare S, et al. Restricted heterogeneity of antibody to gp120 and p24 in AIDS. J Immunol 1988; 141:114-7.
19. Amadori A, Gallo P, Zamarchi R, et al. IgG oligoclonal bands in sera of HIV-l-infected patients are mainly directed against HIV-1 determinants. AIDS Res Hum Retrovir 1990; 6:581-6.
20. Amelio R, Bisselli R, Nisini R, et al. Spectrotype of antigp120 antibodies remains stable over the course of HIV-1 disease. J Acquir Immune Defic Syndr 1992;5:930-5.
21. Kang C, Nara P, Chamat S, et al. Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/ CD4 binding in HIV-1 infected humans. Proc Natl Acad Sci USA 1991;88:6171-5.
22. Chamat S, Nara P, Berquist L, et al. Two major groups of neutralizing anti-gp120 antibodies exist in HIV-1 infected individuals: evidence for epitope diversity around the CD4 attachment site. J Immunol 1992;149:649-55.
23. Wang H, Muller S, Zolla-Pazner H. Human monoclonal and polyclonal anti-HIV-1 antibodies share a common clonotypic specificity. Eur J Immunol 1992;22:1749-55.
24. Cerny J, Hiernaux J. Concept of idiotypic network: description and functions. In: Cerny J, Hiernaux J, eds. Idiotypic network and disease: Washington, D.C.: American Society for Microbiology, 1990:13-29.
25. Marasco WA, Bagley J, Zani C, et al. Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody. J Clin Invest 1992;90:1467-72.
26. Felgenhauer M, Kohl J, Ruker F. Nucleotide sequence of the cDNA encoding the V-regions of the H- and L-chains of a human monoclonal antibody specific to HIV-1 gp41. Nucl Acids Res 1990;18:4927.
27. Moran M, Andris J, Matsumato Y, Capra D, Hersh E. Variable region genes of anti-HIV-1 human monoclonal antibodies: non-restricted use of the V gene repertoire and extensive somatic mutation. Mol Immunol 1993;30:1543-51.
28. Bagley J, Dillon P, Rosen C, Robbinson J, Sodroski J, Marasco W. Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120. Mol Immunol 1994;31:1149-60.
29. K repertoire revealed by in situ hybridization. Mol Immunol 1990;27:935-40.
30. H gene family utilization in human peripheral B cells by in situ hybridization. J Immunol 1991;146:2855-64.
31. Barbas C, Collet T, Amberg W, et al. Molecular profile of an antibody response to HIV-1 as probed by combinatorial phage display libraries. J Mol Biol 1993;230:812-23.
32. Valles-Ayoub Y, Govan H, Braun J. Evolving abundance and clonal pattern of human germinal center B cells during childhood. Blood 1990;76:7-12.
33. H3 gene products: natural ligands for HIV-1 gp120. Science 1993;261:1588-91.
34. H3 (D12 idiotype) B cells in vivo. J Acquir Immune Defic Syndr 1994;7:641-6.
35. Marrack P, Kappler J. The Staphylococcal enterotoxins and their relatives. Science 1990;248:705-11.
36. Matsuda F, Shin E, Nagaoka H, et al. Structure and physical map of 64 variable segments in the 3′ 0.8-megabase region of the human immunoglobulin heavy chain locus. Nature Genet 1993;3:88-94.
37. Clerici M, Shearer G. The Th1-Th2 hypothesis of HIV-1 infection: new insights. Immunol Today 1994;15:575-81.
38. + T cells. Semin Immunol 1993;5:449-55.
39. Adelman D, Matsuda T, Hirano T, Kishimoto T, Saxon A. Elevated serum IL-6 in patients with common variable immunodeficiency associated with a failure in B-cell differentiation. J Allergy Clin Immunol 1990;86:1512-20.
40. Sherr E, Adelman D, Saxon A, Gilly M, Wall R, Sidell N. Retinoic acid induces the differentiation of B cell hybridomas from patients with common variable immunodeficiency. J Exp Med 1988;168:55-60.
41. Saxon A, Giorgi J, Sherr E, Kagan J. Failure of B cells in common variable immunodeficiency to transit from proliferation to differentiation is associated with altered B cell surface molecule display. J Allergy Clin Immunol 1989;84:44-9.
42. Silverman G, Schohenoler R, Accavitti M, Koopman W, Carson D. Structural characterization of the second major cross reactive idiotype group of rheumatoid factors. Arthritis Rheum 1990;33:1347-60.
43. H4 idiotype. Eur J Immunol 1990;20:351-6.
44. H families. J Immunol 1989;142:4054-61.
45. + lymphocytes. Annu Rev Immunol 1989;7:513-9.
46. Lake D, Sugano T, Matsumoto Y, Peterson E, Feorino P, Hersh E. A hybridoma producing human monoclonal antibody specific for glycoprotein 120 kDa of HIV-1. Life Sci 1989;45:iii-x.
47. Lake D, Kawamura T, Tomiyama T, et al. Generation and characterization of a human monoclonal antibody that neutralizes diverse HIV-1 isolates in vitro. AIDS 1992;6:17-242.
48. Sugano T, Masuho Y, Matsumoto Y, et al. Human monoclonal antibodies against glycoproteins of HIV-1. Biochem Biophys Res Commun 1988;155:1105-12.
49. Schutten M, McNight A, Huisman R, et al. Further characterization of an antigenic site of HIV-1 gp120 recognized by virus neutralizing human monoclonal antibodies. AIDS 1993;7:919-23.
50. Wisnewski A, Cavacini L, Kingsbury G, Scadden D, Posner M. Anti-HIV human monoclonal antibody variable region gene usage. J Cell Biochem 1995;suppl.21B:229.
51. Thali M, Furman C. Ho D, et al. Discontinuous, conserved neutralization epitopes overlapping the CD4 binding region of HIV-1 gp120 glycoprotein. J Virol 1992;66:5635-41.
52. Grunow R, Jahn S, Porstmann T, et al. The high efficiency, human B cell immortalizing heteromyeloma CB-F7. J Immunol Meth 1988;106:257-65.
53. Jungbauer A, Tauer C, Wenisch E, et al. Pilot scale production of a human monoclonal antibody against HIV-1. J Biochem Biophys Meth 1989;19:223-9.
54. Ho D, McKeating J, Li X, et al. Conformational epitope on gp120 important in CD4 binding and HIV-1 neutralization identified by a human monoclonal antibody. J Virol 1991;65: 489-93.
55. Gorny M, Gianakakos V, Sharpe S, Pazner S. Generation of human monoclonal antibodies to HIV-1. Proc Natl Acad Sci USA 1989;86:1624-8.
56. Gorny M, Xu J, Gianakakos V, et al. Production of site selected neutralizing human monoclonal antibodies against the third variable domain of HIV-1 envelope glycoprotein. Proc Natl Acad Sci USA 1991;88:3238-42.
57. Posner M, Hideshima T, Cannon T, Mukherjee M, Mayer K, Bryn R. An IgG human monoclonal antibody which reacts with HIV-l/gp120, inhibits virus binding to cells, and neutralizes infection. J Immunol 1991;146:4325-32.